Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingyao Liu

Showing results (681-690 of 698) with videos related to

Pageof 70
Sort By:
Nature Communications|January 31, 2019
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusionMarcos Galasso, Jordan J Feld, Yui Watanabe, et al.
Nature Biotechnology|November 11, 2022
Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editingLiang Chen, Biyun Zhu, Gaomeng Ru, et al.
Nature Biotechnology|June 3, 2020
Dual base editor catalyzes both cytosine and adenine base conversions in human cellsXiaohui Zhang, Biyun Zhu, Liang Chen, et al.
Cell Reports|May 29, 2026
Targeting EP2/EP4-driven expansion of suppressive VSIG4<sup>high</sup> macrophages overcomes immunotherapy resistance in colorectal cancerYao Zhang, Xinyu Yang, Zhiyuan Cheng, et al.
Molecular Cell|July 15, 2019
SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and MetabolismTianshi Wang, Ying Cao, Quan Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to ImmunotherapyShihong Peng, Pan Hu, Yu-Tian Xiao, et al.
Iscience|August 23, 2023
Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concernYu Onodera, Jady Liang, Yuchong Li, et al.
The Journal of Clinical Investigation|November 30, 2021
RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasisZhiying Yue, Xin Niu, Zengjin Yuan, et al.
Nature Communications|February 12, 2024
Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of SrcZhenxi Li, Xinghai Yang, Ruifeng Fu, et al.
Cancer Cell|August 8, 2025
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancersJuanjuan Feng, Xuanzheng Xiao, Xinting Xia, et al.
Pageof 70

Showing results (681-690 of 698) with videos related to

Sort By:
Pageof 70
Nature Communications|January 31, 2019
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusionMarcos Galasso, Jordan J Feld, Yui Watanabe, et al.
Nature Biotechnology|November 11, 2022
Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editingLiang Chen, Biyun Zhu, Gaomeng Ru, et al.
Nature Biotechnology|June 3, 2020
Dual base editor catalyzes both cytosine and adenine base conversions in human cellsXiaohui Zhang, Biyun Zhu, Liang Chen, et al.
Cell Reports|May 29, 2026
Targeting EP2/EP4-driven expansion of suppressive VSIG4<sup>high</sup> macrophages overcomes immunotherapy resistance in colorectal cancerYao Zhang, Xinyu Yang, Zhiyuan Cheng, et al.
Molecular Cell|July 15, 2019
SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and MetabolismTianshi Wang, Ying Cao, Quan Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to ImmunotherapyShihong Peng, Pan Hu, Yu-Tian Xiao, et al.
Iscience|August 23, 2023
Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concernYu Onodera, Jady Liang, Yuchong Li, et al.
The Journal of Clinical Investigation|November 30, 2021
RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasisZhiying Yue, Xin Niu, Zengjin Yuan, et al.
Nature Communications|February 12, 2024
Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of SrcZhenxi Li, Xinghai Yang, Ruifeng Fu, et al.
Cancer Cell|August 8, 2025
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancersJuanjuan Feng, Xuanzheng Xiao, Xinting Xia, et al.
Pageof 70